Register Now for the
2022 AHNS Annual Meeting

Register now for the AHNS 2022 Annual Meeting at COSM, to be held April 27-28, 2022 in Dallas, TX. The scientific program has been thoughtfully designed around the meeting theme “Technology and Innovation”. See below for the Endocrine Section Panels and Debates titled “To Operate is Human, to Ablate is Divine? A Debate About Ablation of Thyroid Lesions” and “Can You See What I See? Finding Parathyroids and Autofluorescence”.

PLEASE NOTE: AHNS Pre-Course registration is separate from the Annual Meeting Registration. For more details go to https://www.ahns.info/meetings/

Register for the Annual Meeting!

To Operate is Human, to Ablate is Divine? A Debate about the Ablation of Thyroid Lesions
Thursday, April 28th at 3:15pm-4:05pm

The ablation approach has moved to the current forefront of approaches for benign, and even some small malignant thyroid lesions. Is ablation a fad, a temporizing strategy, or will it replace many open surgical procedures on the thyroid? Following a brief introduction of the technology, endocrine surgery experts will debate the use of ablative technologies on benign thyroid lesions and microcarcinomas.

Objectives:
1. Recognize the development of ablative technologies and their potential for application to common thyroid pathologies.
2. Appraise the potential benefits of an ablative option for common thyroid pathologies.
3. Select patients and thyroid pathologies best suited for an ablative approach.

Schedule of session topics:

• Introduction – Michael Singer, MD
• An Introduction to Radio Frequency Ablation – Nishant Agrawal, MD
• Surgery vs. Ablation for Thyroid Lesions:
  • Benign Lesions
    • Pro – Ralph Turano, MD
    • Con – Marika Russell, MD
• Microcarcinomas
  • Pro – Jon Russell, MD
  • Con – Maisie Shindo, MD

Can You See What I See? Finding Parathyroids and Autofluorescence                                            Thursday, April 28th at 4:05pm-5:00pm

The discovery of parathyroid gland autofluorescence was a significant advance in understanding of its physiology. Recently, this phenomenon has been leveraged to improve identification of parathyroid glands intraoperatively and is now clinically available. Parathyroid autofluorescence has been extended to gland protection during primary and revision thyroid surgeries and may be value added in parathyroid directed procedures.

Objectives:
1. Articulate the concept of parathyroid autofluorescence.
2. Recognize the morbidity, mortality, and cost of iatrogenic hypoparathyroidism.
3. Formulate the possible integration of autofluorescence in your thyroid surgical practice.

Schedule of session topics:

• Introduction – Brendan C. Stack Jr., MD
• Parathyroid Preservation and the Prevention of Hypoparathyroidism – Brendan C. Stack Jr., MD
• Which Autofluorescence System: Camera vs. Probe – Amanda Silver, MD
• Indocyanine Green and Parathyroid Angiography – Brooke Su-Velez, MD
• Parathyroid Autofluorescence and Surgery for Hyperparathyroidism – Julia Noel, MD
• Question & Answer – Brendan C. Stack Jr., MD